The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
An analysis of FDA-approved drugs: natural products and their derivatives
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
The discovery and development of HMG-CoA reductase inhibitors.
Endo, A. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41379-3 · Cited by 847
Gerwick, W. H., & Moore, B. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.014 · Cited by 601
(2012) · Choice Reviews Online · doi:10.5860/choice.50-0029 · Cited by 509
Natural Product Drug Discovery in the Next Millennium
Cragg, G., & Newman, D. (2001) · Pharmaceutical Biology · doi:10.1076/phbi.39.7.8.5868 · Cited by 448
A natural history of botanical therapeutics
Schmidt, B., Ribnicky, D. M., Poulev, A., Logendra, S., Cefalu, W. T., & Raskin, I. (2008) · Metabolism · doi:10.1016/j.metabol.2008.03.001 · Cited by 309
Mahdi, J. G., Mahdi, A. J., Mahdi, A. J., & Bowen, I. D. (2006) · Cell Proliferation · doi:10.1111/j.1365-2184.2006.00377.x · Cited by 209
An overview of FDA-approved biologics medicines
Kinch, M. S. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.003 · Cited by 164
Self-citationAn analysis of FDA-approved drugs for infectious disease: antibacterial agents
Kinch, M. S., Patridge, E., Plummer, M., & Hoyer, D. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.07.005 · Cited by 115
Self-citationTetracyclines in Biology, Chemistry and Medicine
Nelson, M. J., Greenwald, R. A., & Hillen, W. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8306-1 · Cited by 110
Past, present, and future of antimicrobial agents
Moellering, R. C. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80279-4 · Cited by 62
Plant Sources of Drugs and Chemicals
Gerwick, W. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384719-5.00111-8 · Cited by 8
Cited by
Brown, D. G., & Boström, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01409 · Cited by 1,964
Counting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,241
Natural Products as Platforms To Overcome Antibiotic Resistance
Rossiter, S. E., Fletcher, M. H., & Wuest, W. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00283 · Cited by 622
Natural Products as Anticancer Agents: Current Status and Future Perspectives
Naeem, A., Hu, P., Yang, M., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022) · Molecules · doi:10.3390/molecules27238367 · Cited by 607
Metadata
- Authors
- Patridge, E., Gareiss, P., Kinch, M. S., & Hoyer, D.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 21
- Issue
- 2
- Pages
- 204-207
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W1991412566
- Cited by
- 831
- References
- 14
- FWCI
- 26.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.